DalsnaFinance › IPOs › Inhibrx Biosciences Inc › IPO
Inhibrx, Inc. completed its initial public offering on NASDAQ on August 19, 2020, pricing at $17.00 a share.
| Ticker | INBX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | August 19, 2020 |
| Offering price | $17.00 |
| Shares offered | 7,000,000 |
| Total raised | $119M |
Inhibrx, Inc. sold 7,000,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $119 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $119 million total recorded for the deal.
Inhibrx, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Inhibrx, Inc.. This page is general information, not investment advice.